• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProMIS Neurosciences Inc. - Common Shares (NQ:PMN)

0.4376 -0.0290 (-6.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 457,178
Open 0.4490
Bid (Size) 0.4370 (1)
Ask (Size) 0.4800 (50)
Prev. Close 0.4666
Today's Range 0.4211 - 0.4666
52wk Range 0.3800 - 1.590
Shares Outstanding 32,689,190
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
September 05, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 05, 2025
 
Via Benzinga

Performance

YTD
-54.4%
-54.4%
1 Month
+3.2%
+3.2%
3 Month
-6.9%
-6.9%
6 Month
-31.1%
-31.1%
1 Year
-57.9%
-57.9%

More News

Read More
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
September 03, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
August 13, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
August 01, 2025
Via Benzinga
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
July 29, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
What's going on in today's pre-market session
July 28, 2025
Via Chartmill
ProMIS Neurosciences Announces Private Placement Financing
July 28, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
July 23, 2025
Via Benzinga
Which stocks are experiencing notable movement on Tuesday?
July 22, 2025
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
July 22, 2025
Via Chartmill
Gapping stocks in Tuesday's session
July 22, 2025
Via Chartmill
Which stocks are moving before the opening bell on Tuesday?
July 22, 2025
Via Chartmill
ProMIS Neurosciences Announces Private Placement Financing
July 22, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules
July 22, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Monday?
July 21, 2025
Via Chartmill
Monday's session: most active stocks
July 21, 2025
Via Chartmill
These stocks have an unusual volume in today's session
July 21, 2025
Via Chartmill
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results
July 21, 2025
Via Benzinga
Dow Gains 50 Points; Verizon Earnings Top Views
July 21, 2025
Via Benzinga
Topics Stocks
Get insights into the top gainers and losers of Monday's pre-market session.
July 21, 2025
Via Chartmill
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
July 21, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson (NYSE: MCK) Sends “FOCUSfactor” Exploding Across North America – More Stocks Inside
July 14, 2025
Via AB Newswire
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
July 08, 2025
Via Benzinga
ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
June 17, 2025
From ProMIS Neurosciences Inc.
Via GlobeNewswire

Frequently Asked Questions

Is ProMIS Neurosciences Inc. - Common Shares publicly traded?
Yes, ProMIS Neurosciences Inc. - Common Shares is publicly traded.
What exchange does ProMIS Neurosciences Inc. - Common Shares trade on?
ProMIS Neurosciences Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ProMIS Neurosciences Inc. - Common Shares?
The ticker symbol for ProMIS Neurosciences Inc. - Common Shares is PMN on the Nasdaq Stock Market
What is the current price of ProMIS Neurosciences Inc. - Common Shares?
The current price of ProMIS Neurosciences Inc. - Common Shares is 0.4376
When was ProMIS Neurosciences Inc. - Common Shares last traded?
The last trade of ProMIS Neurosciences Inc. - Common Shares was at 10/17/25 04:00 PM ET
What is the market capitalization of ProMIS Neurosciences Inc. - Common Shares?
The market capitalization of ProMIS Neurosciences Inc. - Common Shares is 14.30M
How many shares of ProMIS Neurosciences Inc. - Common Shares are outstanding?
ProMIS Neurosciences Inc. - Common Shares has 14M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap